-
Mashup Score: 3
The FDA has granted orphan drug designation to BLR-200, an investigational therapy for the treatment of scleroderma, according to a press release from manufacturer. The drug, a CCN3-derived peptide, is being developed by BLR Bio as part of the Helix 51 Bioscience Incubator at Rosalind Franklin University of Science and Medicine, in North Chicago, Illinois.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1
The FDA has approved an investigational new drug application for Kyverna Therapeutics’ KYV-101, an anti-CD19 chimeric antigen receptor T-cell therapy for diffuse cutaneous systemic sclerosis, according to a company press release.The FDA decision marks the third IND clearance for KYV-101, following earlier authorizations for lupus nephritis and B cell-driven autoimmune diseases. Kyverna is
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Is competition heating up in the CD19-CAR T-cell space?🔥 ✳️@KyvernaT's KYV-101 snags FDA clearance for #scleroderma just days after @CabalettaBio's CABA-201 -- what's coming next? #RheumTwitter Read more🔽https://t.co/BFNtK8NyjW
-
-
Mashup Score: 0Autoantibodies could help predict cancer risk in scleroderma - 10 month(s) ago
The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were tied to reduced risk.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet-
#Autoantibodies could help predict cancer risk in #scleroderma 👉https://t.co/ozjJtj86fs @MDEdgeHemOnc https://t.co/DbIjK1StpZ
-
-
Mashup Score: 0Extracellular Vesicles Propagate Lung Fibrosis in Systemic Sclerosis. - 10 month(s) ago
Objectives Systemic Sclerosis (SSc) has the highest mortality rate among the rheumatic diseases, with lung fibrosis leading as the cause of death. A characteristic of severe SSc-related lung fibrosi…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Latest HeadlinesTweet-
Extracellular vesicles could aid spread of #scleroderma-caused #fibrosis throughout body @MUSCHealth https://t.co/rGOVzThmky https://t.co/Y33df25pz9
-
-
Mashup Score: 0Scleroderma - 11 month(s) ago
About this Quiz Answer questions and review cases on these topics and more. Dyspnea Raynaud’s phenomenon Scleroderma renal crisis Below are sample questions you can expect to see in this quiz. Which of the following are consistent with the histologic findings of the kidney in patients with scleroderma renal crises? A 32-year-old female…
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Answer questions and review cases on Scleroderma in a learning mode of your choosing with Rheum and Boards: https://t.co/X3bPZMtgP8 #Scleroderma #Rheumatology #RheumandBoards https://t.co/J3hl2N8MRR
-
-
Mashup Score: 0
For this interview segment, Dr. Arkin discussed the biggest points she hopes dermatologists will take away from National Scleroderma Awareness Month this year.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In this @HCPLiveNews interview segment, Dr. Lisa Arkin described the importance of raising awareness of #scleroderma, noting a lack of treatments and that the disease predominantly affects women: https://t.co/LpDoll799K
-
-
Mashup Score: 0
This interview with Dr. Arkin involved a discussion, in honor of June being National Scleroderma Awareness Month, of information on underlying causes and new research on the skin condition.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In this @HCPLiveNews interview, Lisa Arkin, MD, spoke on her experiences in the dermatology field treating patients with #scleroderma, sharing her insights on the skin condition and its future: https://t.co/Leld4hUfmt
-
-
Mashup Score: 0Lisa Arkin, MD: New Research, Therapies for Patients with Scleroderma - 12 month(s) ago
In this segment of her interview, Dr. Arkin was asked about news, recent research, and therapies for patients with scleroderma, in honor of National Scleroderma Awareness Month.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In this @HCPLiveNews interview, Dr. Lisa Arkin was asked about recent research and therapies for patients with #scleroderma, in honor of National Scleroderma Awareness Month. Check out the clip here: https://t.co/fT5yXqBV9m
-
-
Mashup Score: 0Dermatology | Medical News & Expert Insight | HCPLive - 12 month(s) ago
The dermatology condition center is a comprehensive resource for clinical news and expert insights on dermatology. Read more at HCPLive.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In honor of June being National Scleroderma Awareness Month, we will be covering stories featuring news and information about #scleroderma research. Want to learn more? View our #dermatology page or follow @HCPLiveNews for the latest updates: https://t.co/AEVXZmptcE
-
-
Mashup Score: 3
Objective We evaluated the epidemiology, manifestations, serology, comorbidities, and survival among patients with systemic sclerosis (SSc) with and without sarcoidosis. Methods We conducted a retrospective cohort study comparing patients with SSc with and without sarcoidosis. All patients fulfilled the American College of Rheumatology/European Alliance of Associations for Rheumatology…
Source: The Journal of RheumatologyCategories: Latest Headlines, RheumatologyTweet-
Research Article Epidemiology and Survival of Systemic Sclerosis–Sarcoidosis Overlap Syndrome 📰 https://t.co/TPsp0lshsl #epidemiology #sarcoidosis #scleroderma #survival #systemicsclerosis https://t.co/V0oRMAuX7M
-
📢 @US_FDA has granted orphan drug designation to BLR-200, an investigational therapy for the treatment of #scleroderma The drug is being developed by BLR Bio at the Helix 51 Bioscience Incubator out of @RFUniversity Check Healio for more info 👇 https://t.co/ep8fYExkxu